pillbase.ru

Omvoh

Active substance: mirikizumab

mirikizumab

Centralised EU authorisationActive

Marketing holder: Eli Lilly Nederland B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 5
  • Omvoh
    INJECTION, SOLUTION · MIRIKIZUMAB 100 mg/mL
    0002-8011
    Eli Lilly and Company
  • Omvoh
    INJECTION, SOLUTION · MIRIKIZUMAB 100 mg/mL
    0002-1442
    Eli Lilly and Company
  • Omvoh
    INJECTION, SOLUTION · MIRIKIZUMAB 20 mg/mL
    0002-7575
    Eli Lilly and Company
  • Omvoh
    INJECTION, SOLUTION · MIRIKIZUMAB 100 mg/mL
    0002-8870
    Eli Lilly and Company
  • Omvoh
    INJECTION, SOLUTION · MIRIKIZUMAB 100 mg/mL
    0002-3116
    Eli Lilly and Company
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-45de-7788-abbd-5102d5b6691a,01a1208c-483f-7b30-8a8f-09e3129a9642,01a12091-067d-7d53-b48a-104d5fb747f5,01a1209c-db2e-7653-a319-9c411aef9ea8,01a1209d-69cc-7de0-ae9c-4bb2d75c507d;count=5 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005122
Registration status
Active
ATC code
L04AC
Sources
  • product · EMA · EMEA/H/C/005122 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005122 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005122 · Verified 2026-10-09